Glycosylation-modified antigens as a tolerance-inducing vaccine platform prevent anaphylaxis in a pre-clinical model of food allergy

The only FDA-approved oral immunotherapy for a food allergy provides protection against accidental exposure to peanuts. However, this therapy often causes discomfort or side effects and requires long-term commitment. Better preventive and therapeutic solutions are urgently needed. We develop a toler...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cell reports. Medicine 2024-01, Vol.5 (1), p.101346, Article 101346
Hauptverfasser:	Cao, Shijie, Maulloo, Chitavi D, Raczy, Michal M, Sabados, Matthew, Slezak, Anna J, Nguyen, Mindy, Solanki, Ani, Wallace, Rachel P, Shim, Ha-Na, Wilson, D Scott, Hubbell, Jeffrey A
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!